(NASDAQ: FTRE) Fortrea Holdings's forecast annual revenue growth rate of -2.24% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 152.36%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.68%.
Fortrea Holdings's revenue in 2025 is $2,696,400,000.On average, 4 Wall Street analysts forecast FTRE's revenue for 2025 to be $223,797,690,000, with the lowest FTRE revenue forecast at $222,831,000,000, and the highest FTRE revenue forecast at $225,027,000,000. On average, 4 Wall Street analysts forecast FTRE's revenue for 2026 to be $231,286,500,000, with the lowest FTRE revenue forecast at $228,558,690,000, and the highest FTRE revenue forecast at $234,018,000,000.
In 2027, FTRE is forecast to generate $241,085,790,000 in revenue, with the lowest revenue forecast at $237,701,070,000 and the highest revenue forecast at $244,470,600,000.